Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AROA BIOSURGERY LIMITED Share Issue/Capital Change 2021

Jul 6, 2021

64426_rns_2021-07-06_2f1d8521-fd45-48cb-8077-d9ab630e9181.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

AROA BIOSURGERY LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday July 07, 2021

Details of +securities that have ceased

Number of
ASX +security +securities that The +securities have Date of
code Security description have ceased ceased due to cessation
ARXAD OPTION EXPIRING 120,000 Lapse of conditional right to 07/07/2021
30-SEP-2025 EX $1.34 securities because the
conditions have not been, or
have become incapable of
being, satisfied

Refer to next page for full details of the announcement

Notification of cessation of +securities

1 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Announcement Details

1.1 Name of +Entity

AROA BIOSURGERY LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type

ARBN

Registration Number 638867473

1.3 ASX issuer code

ARX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

7/7/2021

Notification of cessation of +securities

2 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

ARXAD : OPTION EXPIRING 30-SEP-2025 EX $1.34

Unquoted +equity securities that have ceased

Number of securities that have ceased

120,000

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation Is the entity paying any consideration for the cessation? No 7/7/2021

Any other information the entity wishes to notify to ASX about the cessation?

None

Notification of cessation of +securities

3 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
Total number of
ASX +security code and description +securities on issue
ARX : ORDINARY FULLY PAID 301,076,111
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
Total number of
ASX +security code and description +securities on issue
ARXAD : OPTION EXPIRING 30-SEP-2025 EX $1.34 1,753,200
ARXAA : OPTION EXPIRING 23-JUL-2025 EX 75C 5,876,975
ARXAB : OPTION EXPIRING 01-OCT-2028 EX 10C 2,447,700
ARXAC : OPTION EXPIRING 30-NOV-2029 EX 11C 1,275,000
ARXAE : OPTION EXPIRING 31-MAR-2025 EX $1.15 350,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities

4 / 4